Congressi della International Gastric Cancer Association - IGCA:
3rd International Gastric Cancer Congress, Seul, Korea, April 27-30, 1999
4th International Gastric Cancer Congress, New York, US, April 29-May 2, 2001
5th International Gastric Cancer Congress, Rome, May 4-7, 2003
6th International Gastric Cancer Congress, Yokohama, Japan, May 4-7, 2005
7th International Gastric Cancer Congress, San Paulo, Brazil, May 9-12, 2007
8th International Gastric Cancer Congress, Krakow, Poland, June 10-13, 2009
9th International Gastric Cancer Congress, Seul, Korea, April 20-23, 2011
10th International Gastric Cancer Congress, Verona, Italy, June 19-22, 2013
EGC Rationale of lymphadenectomy: an italian multicentric study.
EGC in the province of Forlì. Follow up of 412 patients in a hight risk region for gastric cancer.
Lymph node metastases of adenocarcinoma of the gastric cardia with special reference to abdominal lymphatic spread: an italian multicentric study.
A clinicopathological analisis of tumor recurrence following curative surgery for gastric cancer. The result of an italian multicentric study.
Occult micrometastases in patients with EGC. Have they a real significative prognostic impact?
Multiple non gastric malignancy in EGC patients 2001. Evaluation of p27, proliferative (Mib 1) mitotic (Mi) and apoptotic (A1) indices in EGC. Results of an Italian Research Group for Gastric Cancer study.
Survival benefit of extended D2 Lymphadenectomy in gastric cancer with involvement of N2 lymph nodes. An Italian Multicentric Study.
Koodama’s type as independent prognostic factor in EGC: evaluation of 452 patients.
The number of positive nodes is directly related to the number of exised nodes, particularly in advanced gastric cancer. Results of an Italian Research Group for Gastric Cancer study.
H. pylori cag-A structural types and gastric carcinoma.
Molecular features of gastric cancer and their clinical implication. Results of an Italian Research Group for Gastric Cancer.
Ca 72-4 an highly specific index of tumour recurrence after curative surgery for gastric cancer.
Intraoperative peritoneal dissemination of free gastric cancer cells.
Does resection line involvement affect prognosis in early gastric cancer?
Scoring system for the prediction of recurrence after radical surgery for gastric cancer. Prospective multicentre study.
Immunohistochemical evaluation of intramucosal adenocarcinoma of the stomach. A purpose of new classification.
Iron deficiency anemia after subtotal gastrectomy for gastric cancer.
pT2 gastric Cancer. Clinicopathological prognostic factors.
Prognostic value of lymph nodes status in gastric cancer patients who undergo radical resection.
Gastric cancer infiltrated resection line. A multicentric study.
Familial gastric cancer: analysis of 238 families.
Postoperative complications and mortality following D2 vs D3 lymphadenectomy. A single centre experience on 304 consecutive patients.
High response rate of a new induction chemo-radiotherapy regimen for gastroesophageal junction carcinoma.
Early onset gastric cancer: immunohistological study of APC, B catenin, E Caderinand mismatch repair proteins.
Microsatellite instability is an independent prognostic factor in T2 and T3 gastric cancer and correlates with distinct clinicopathological features.
Postoperative complications and functional results after subtotal gastrectomy with Billroth II reconstruction. A prospective observational study.
Preoperative locoregional staging of gastric cancer according to Japanese Classification: feasibility and accuracy of MDCT.
Prospective validation study of the Italian Research Gastric Cancer Group (IRGCG) prognostic score. Preliminary data.
Nodal involvement in gastric cancer according to depth of tumour invasion and site. Study on 545 patients.
Prognostic value of micrometastases in serosal negative pN0 gastric cancer.
Surgeon role in gastric cancer: a 11 year audit in a secondary care centre.
Subtotal gastrectomy as treatment of distal multifocal early gastric cancer.
Early gastric cancer: strategies and management.
Prospective validation of the IRGC prognostic score. A multicentric study on 961 consecutive cases.
Duodenal fistula after elective gastrectomy for malignant disease. An Italian retrospective
Super extended (D3) lymphadenectomy in advanced gastric cancer: an experience from Italian high volume centres.
Metachronous hepatic metastases from gastric carcinoma; prognostic factors from a multicentric Italian survey.
Expression and role of HERG 1 gene and HERG 1 potassium channel in human gastric cancer.
Super extended (D3) lymphadenectomy in advanced gastric cancer surgery.
Extended lymphadenectomy is not associated with an increase in post operative morbidity/mortality in specialized centres. A GIRCG study.
ARLTS 1 and risk of gastric cancer.
Risk factors for complications after extended (D2) and superextended (D3) lymphadenectomy. A prospective observational study on 330 patients.
Clinical outcome and genotype of helicobacter pylori in gastric cancer: preliminary study for multimember study.
Gene expression and signature of microsatellite instability in gastric cancer.
Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. Prognostic value of the site of metastasis and proposal of a specific staging system.
Neoadjuvant combined modality therapy with weekly docetaxel and cisplatin 5-fluorouracil continuous infusion and concurrent radiotherapy provides high pathological response rate in adenocarcinoma of the EJC.
Preoperative endoscopic administration of liposomal endocapsulated daunorubicin in gastric cancer patients. Preliminary study on tissue and nodes concentrations.
Mucosectomy as a valid choice for the treatment of preneoplastic lesions and early gastric cancer of the stomach. The Experience of the Italian Research Group for Gastric Cancer (IRGC).
Changing clinical and pathological features of gastric cancer in the period 1991-2005. Astatistical evaluation of the Italian Research Group for Gastric Cancer (IRGC) data base on 2843 patients.
Gastrointestinal stromal tumors (GISTs) of the stomach: a preliminary report of the Italian Research Group for Gastric Cancer (IRGC) data base on 2843 patients.
Molecular profiles of EGC: an early phase of neoplastic disease with different clinical behaviours. A multicentric western analysis of prognostic factors in advanced node negative gastric cancer patients.
Bipolar exclusion as treatment for esophagojejunal severe leakage.
Robotic D2 lymphadenectomy for gastric cancer.
Our experience on Billroth 2 anastomosis after subtotal gastrectomy. Results on 513 patients. On behalf of the Italian Research Group for Gastric Cancer (IRGC) data base on 2843 patients.
Site and perigastric nodal status are the most important predictors of paraortic nodal involvement. An Italian Research Group for Gastric Cancer (IRGC) study.
Super extended lymphadenectomy (D3) in advanced gastric Cancer. Results from two Italian centres.
Promoter X ray cross-complementing group 1 (XRCC1) -77T/C gene polimorfism is associated with increased risk of gastric carcinoma.
Gastric cancer with microsatellite instability at multiple loci shows a strong correlation with better long term survival.
Absence of Helicobacter Pylori infection is a negative prognostic factor in gastric cancer.
N ratio in gastric cancer patients treated by D1 lymphadenectomy.
Influence of perioperative blood transfusions on prognosis of gastric cancer patients and role of splenectomy (on behalf of Italian Research Group for Gastric Cancer (IRGC).
Hypermetilation phenotype of E-caderin promoter in gastric cancer and clinical implication.
Response to induction therapy in esophago gastric junction carcinoma evaluated either by standard tumour regression grade or by residual foci dimension.
Feasibility of endoscopic mucosal dissection (ESD) compared with endoscopic mucosal resection (EMR) for the treatment of EGC in an Italian cohort.
Paraortic nodal dissection in advanced gastric cancer: is still indicated?
Clinical trials in the west. How to pave the way?
The road to R0: a different pathway for the elderly?
Treatment of peritoneal dissemination from gastric cancer by intraperitoneal chemohypertermic peritoneal perfusion.
Super-extended (D3) lymphadenectomy (para-aortic lymph node dissection) in the treatment of advanced gastric cancer.
Is EGJ adenocarcinoma a real esophageal cancer?
N categories, although necessary, are not homogeneous as regards survival.
The COLEGAS study: safety of prophylactic cholecistectomy during gastrectomy for cancer. An Interim analysis.
Structural CDH1 alteration in gastric cancer as novel prognostic biomarker.
Naso-gastric/jejunal decompression after subtotal distal gastrectomy. Preliminary results of a multicenter randomized trial (on behalf of the Italian Research Group for Gastric Cancer – IRGGC).
Process and outcome indicators for the evaluation of surgical activity in high-risk area for gastric cancer.
What does it change with the new AJCC/UICC TNM classification? Statistical evaluation of 2416 patients from the IRGGC database.
End-to-end stapled esophagogastric anastomosis after distal esophagectomy and proximal gastrectomy: proposal of a new technique.
Validation of the new AJCC TNM staging system for gastric cancer in a large cohort of patients (N=2,155): focus on the T category.
Endoscopic treatment of GIST (gastrointestinal stromal tumor).
A randomized phase II study of pre-operative or perioperative docetaxel, oxlaliplatin, capecitabine (DOX) regimen in patients with locally advanced resectable gastric cancer.
High accuracy of multi-slices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study.
Multifaceted heterogeneity of HER-2/Neu in gastric carcinoma with potential clinical impact.
Preoperative multidetector-row computed tomography scan staging for lymphatic gastric cancer spread.
Different pathological features and prognosis of gastric cancer patients coming from high-risk and low-risk areas of Italy.
Link to site